Article(id=1330127190273929227, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1330127189372153867, articleNumber=null, orderNo=null, doi=10.13683/j.wph.2018.02.001, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1507651200000, receivedDateStr=2017-10-11, revisedDate=1512662400000, revisedDateStr=2017-12-08, acceptedDate=null, acceptedDateStr=null, onlineDate=1795056634729, onlineDateStr=2026-11-19, pubDate=1518192000000, pubDateStr=2018-02-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1795056634729, onlineIssueDateStr=2026-11-19, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1795056634729, creator=13701087609, updateTime=1795056634729, updator=13701087609, issue=Issue{id=1330127189372153867, tenantId=1146029695717560320, journalId=1319690329412173987, year='2018', volume='39', issue='2', pageStart='S9', pageEnd='144', issueExtLink='null', onlineDate='null', pubDate='1518192000000', pubDateStr='2018-02-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1795056634514, creator='13701087609', updateTime=1795056680728, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1330127383656510048, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1330127189372153867, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1330127383656510049, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1330127189372153867, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=73, endPage=79, ext={EN=ArticleExt(id=1330127190563336204, articleId=1330127190273929227, tenantId=1146029695717560320, journalId=1319690329412173987, language=EN, title=Research progress on the diagnosis and treatment of primary membranous nephropathy, columnId=1325221107665612978, journalTitle=World Clinical Drug, columnName=Topic, runingTitle=null, highlight=null, articleAbstract=

Primary membranous nephropathy (PMN) [or idiopathic membranous nephropathy (IMN)] belongs to one of the most common pathological type of membranous glomerular nephropathy. As the development of anti-phospholipase A2 receptor antibody and anti-thrombospondin type-1 domain-containing 7A antibody for IMN treatment, the new immune-suppressants such as tacrolimus, and monoclonal antibodies such as rituximab have been successively used in IMN treatment. This review describes the recent progress in IMN diagnosis and its treatment.

, authors=Yang-bin PAN, Jian-xin WAN*, authorsList=Yang-bin PAN, Jian-xin WAN, authorCompany=null, correspAuthors=Jian-xin WAN, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1330127190970183695, articleId=1330127190273929227, tenantId=1146029695717560320, journalId=1319690329412173987, language=CN, title=原发性膜性肾病的诊治进展, columnId=1330127190638833678, journalTitle=世界临床药物, columnName=医药专论·慢性肾脏病的诊疗专题, runingTitle=null, highlight=null, articleAbstract=

原发性膜性肾病(PMN)[又称特发性膜性肾病(IMN)]是膜性肾病的一种主要病理类型,随着抗磷脂酶A2受体抗体、抗Ⅰ型血小板反应蛋白7A域抗体等的相继开发,新型免疫抑制剂(如他克莫司)、单克隆抗体(如利妥昔单抗)等药物在IMN中的应用,IMN的诊断和治疗得到较大进展,本文综述IMN的诊断和治疗进展。

, authors=潘阳彬, 万建新*, authorsList=潘阳彬, 万建新, authorCompany=null, correspAuthors=万建新, authorNote=

潘阳彬,副主任医师,副教授,硕士生导师,研究方向:肾小球疾病的发病机制及治疗,血液净化治疗。

, correspAuthorsNote=
万建新,主任医师,教授,博士生导师,研究方向:损伤肾脏的修复与再生。
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=jqRB1n1VVvA/hKRQ+EOe6g==, magXml=9DRv7zm8Btu2WyjpBX0ZWA==, pdfUrl=null, pdf=pzevpbBvgPBC+6t3WCunJw==, pdfFileSize=956145, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=b7xDOWIX47FKjRaSYGH1eQ==, mapNumber=null, fund=null)}, authors=[Author(id=1330127191259590676, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127190273929227, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330127191339282454, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127190273929227, authorId=1330127191259590676, language=EN, stringName=Yang-bin PAN, firstName=Yang-bin, middleName=null, lastName=PAN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Nephrology, First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330127191406391319, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127190273929227, authorId=1330127191259590676, language=CN, stringName=潘阳彬, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=福建医科大学附属第一医院肾内科,福州 350005, bio={"content":"

潘阳彬,副主任医师,副教授,硕士生导师,研究方向:肾小球疾病的发病机制及治疗,血液净化治疗。

"}, bioImg=null, bioContent=

潘阳彬,副主任医师,副教授,硕士生导师,研究方向:肾小球疾病的发病机制及治疗,血液净化治疗。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330127191167315984, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127190273929227, xref=null, ext=[AuthorCompanyExt(id=1330127191175704593, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127190273929227, companyId=1330127191167315984, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Nephrology, First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, China), AuthorCompanyExt(id=1330127191184093202, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127190273929227, companyId=1330127191167315984, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=福建医科大学附属第一医院肾内科,福州 350005)])]), Author(id=1330127191469305881, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127190273929227, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1330127191561580571, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127190273929227, authorId=1330127191469305881, language=EN, stringName=Jian-xin WAN, firstName=Jian-xin, middleName=null, lastName=WAN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=Department of Nephrology, First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330127191641272348, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127190273929227, authorId=1330127191469305881, language=CN, stringName=万建新, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=福建医科大学附属第一医院肾内科,福州 350005, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330127191167315984, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127190273929227, xref=null, ext=[AuthorCompanyExt(id=1330127191175704593, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127190273929227, companyId=1330127191167315984, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Nephrology, First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, China), AuthorCompanyExt(id=1330127191184093202, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127190273929227, companyId=1330127191167315984, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=福建医科大学附属第一医院肾内科,福州 350005)])])], keywords=[Keyword(id=1330127191750324253, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127190273929227, language=EN, orderNo=1, keyword=primary membranous nephropathy (PMN)), Keyword(id=1330127191813238814, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127190273929227, language=EN, orderNo=2, keyword=idiopathic membranous nephropathy (IMN)), Keyword(id=1330127191880347679, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127190273929227, language=EN, orderNo=3, keyword=diagnosis), Keyword(id=1330127191955845152, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127190273929227, language=EN, orderNo=4, keyword=treatment), Keyword(id=1330127192085868577, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127190273929227, language=CN, orderNo=1, keyword=原发性膜性肾病(PMN)), Keyword(id=1330127192152977442, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127190273929227, language=CN, orderNo=2, keyword=特发性膜性肾病(IMN)), Keyword(id=1330127192253640739, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127190273929227, language=CN, orderNo=3, keyword=诊断), Keyword(id=1330127193813921828, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127190273929227, language=CN, orderNo=4, keyword=治疗)], refs=[Reference(id=1330127194153660456, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127190273929227, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=Xu X, Wang G, Chen N, et al. Long-term exposure to air pollution and increased risk of membranous nephropathy in China[J]. J Am Soc Nephrol, 2016, 27(12): 3739-3746., articleTitle=null, refAbstract=null), Reference(id=1330127194245935145, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127190273929227, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=Zhu P, Zhou FD, Wang SX, et al. Increasing frequency of idiopathic membranous nephropathy in primary glomerular disease: a 10-year renal biopsy study from a single Chinese nephrology centre[J]. Nephrology (Carlton), 2015, 20(8): 560-566., articleTitle=null, refAbstract=null), Reference(id=1330127194325626922, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127190273929227, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=Glassock RJ. The pathogenesis of idiopathic membranous nephropathy: a 50-year odyssey[J]. Am J Kidney Dis, 2010, 56(1): 157-167., articleTitle=null, refAbstract=null), Reference(id=1330127194392735787, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127190273929227, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=Mundel P, Shankland SJ. Podocyte biology and response to injury[J]. J Am Soc Nephrol, 2002, 13(12): 3005-3015., articleTitle=null, refAbstract=null), Reference(id=1330127194459844652, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127190273929227, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=Huang CC, Lehman A, Albawardi A, et al. IgG subclass staining in renal biopsies with membranous glomerulonephritis indicates subclass switch during disease progression[J]. Mod Pathol, 2013, 26(6): 799-805., articleTitle=null, refAbstract=null), Reference(id=1330127194531147821, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127190273929227, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=Beck LJ, Bonegio RG, Lambeau G, et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy[J]. N Engl J Med, 2009, 361(1): 11-21., articleTitle=null, refAbstract=null), Reference(id=1330127194606645294, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127190273929227, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=Sueta S, Kondo M, Matsubara T, et al. Membranous nephropathy associated with type 1 autoimmune pancreatitis and dominant glomerular IgG4 deposit[J]. CEN Case Rep, 2014, 3(1): 18-23., articleTitle=null, refAbstract=null), Reference(id=1330127194698919983, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127190273929227, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=Filippone EJ. Idiopathic membranous nephropathy and IgG4: an interesting relationship[J]. Clin Nephrol, 2014, 82(1): 7-15., articleTitle=null, refAbstract=null), Reference(id=1330127194782806064, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127190273929227, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=Hu SL, Wang D, Gou WJ, et al. Diagnostic value of phospholipase A2 receptor in idiopathic membranous nephropathy: a systematic review and meta-analysis[J]. J Nephrol, 2014, 27(2): 111-116., articleTitle=null, refAbstract=null), Reference(id=1330127194849914929, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127190273929227, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=Hofstra JM, Wetzels JF. Phospholipase A2 receptor antibodies in membranous nephropathy: unresolved issues[J]. J Am Soc Nephrol, 2014, 25(6): 1137-1139., articleTitle=null, refAbstract=null), Reference(id=1330127194908635186, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127190273929227, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=De-Vriese AS, Glassock RJ, Nath KA, et al. A proposal for a serology-based approach to membranous nephropathy[J]. J Am Soc Nephrol, 2017, 28(2): 421-430., articleTitle=null, refAbstract=null), Reference(id=1330127194975744051, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127190273929227, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=Wang C, Lu H, Yang C, et al. Progress on the M-type phospholipase A2 receptor in idiopathic membranous nephropathy[J]. Chin Med J (Engl), 2014, 127(10): 1960-1963., articleTitle=null, refAbstract=null), Reference(id=1330127195072213044, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127190273929227, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=Koziol M, Sikora A, Koziol-Montewka M, et al. Preliminary results of research on a new marker of idiopathic membranous nephropathy: anti-PLA2R[J]. Pol Merkur Lekarski, 2014, 36(213): 171-174., articleTitle=null, refAbstract=null), Reference(id=1330127195160293429, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127190273929227, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=Dahnrich C, Komorowski L, Probst C, et al. Development of a standardized ELISA for the determination of autoantibodies against human M-type phospholipase A2 receptor in primary membranous nephropathy[J]. Clin Chim Acta, 2013, 421(1): 213-218., articleTitle=null, refAbstract=null), Reference(id=1330127195235790902, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127190273929227, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=Behnert A, Schiffer M, Muller-Deile J, et al. Antiphospholipase A(2) receptor autoantibodies: a comparison of three different immunoassays for the diagnosis of idiopathic membranous nephropathy[J]. J Immunol Res, 2014, 2014: 143274. doi: 10.1155/2014/143274., articleTitle=null, refAbstract=null), Reference(id=1330127195307094071, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127190273929227, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=Stanescu HC, Arcos-Burgos M, Medlar A, et al. Risk HLA-DQA1 and PLA(2)R1 alleles in idiopathic membranous nephropathy[J]. N Engl J Med, 2011, 364(7): 616-626., articleTitle=null, refAbstract=null), Reference(id=1330127195395174456, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127190273929227, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=Bullich G, Ballarin J, Oliver A, et al. HLA-DQA1 and PLA2R1 polymorphisms and risk of idiopathic membranous nephropathy[J]. Clin J Am Soc Nephrol, 2014, 9(2): 335-343., articleTitle=null, refAbstract=null), Reference(id=1330127195458089017, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127190273929227, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=Cui G, Zhang L, Xu Y, et al. Development of a high resolution melting method for genotyping of risk HLA-DQA1 and PLA2R1 alleles and ethnic distribution of these risk alleles[J]. Gene, 2013, 514(2): 125-130., articleTitle=null, refAbstract=null), Reference(id=1330127195529392186, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127190273929227, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=Lv J, Hou W, Zhou X, et al. Interaction between PLA2R1 and HLA-DQA1 variants associates with anti-PLA2R antibodies and membranous nephropathy[J]. J Am Soc Nephrol, 2013, 24(8): 1323-1329., articleTitle=null, refAbstract=null), Reference(id=1330127195592306747, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127190273929227, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=Tomas NM, Beck LJ, Meyer-Schwesinger C, et al. Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy[J]. N Engl J Med, 2014, 371(24): 2277-2287., articleTitle=null, refAbstract=null), Reference(id=1330127195676192828, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127190273929227, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=Iwakura T, Ohashi N, Kato A, et al. Prevalence of enhanced granular expression of thrombospondin type-1 domain-containing 7A in the glomeruli of Japanese patients with idiopathic membranous nephropathy[J]. PLoS One, 2015, 10(9): 138-141., articleTitle=null, refAbstract=null), Reference(id=1330127195734913085, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127190273929227, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=Larsen CP, Cossey LN, Beck LH. THSD7A staining of membranous glomerulopathy in clinical practice reveals cases with dual autoantibody positivity[J]. Mod Pathol, 2016, 29(4): 421-426., articleTitle=null, refAbstract=null), Reference(id=1330127195789439038, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127190273929227, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=Hoxha E, Harendza S, Pinnschmidt HO, et al. Spontaneous remission of proteinuria is a frequent event in phospholipase A2 receptor antibody-negative patients with membranous nephropathy[J]. Nephrol Dial Transplant, 2015, 30(11): 1862-1869., articleTitle=null, refAbstract=null), Reference(id=1330127195890102335, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127190273929227, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=Hoxha E, Wiech T, Stahl PR, et al. A Mechanism for cancer-associated membranous nephropathy[J]. N Engl J Med, 2016, 374(20): 1995-1996., articleTitle=null, refAbstract=null), Reference(id=1330127195969794112, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127190273929227, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=Hoxha E, Beck LJ, Wiech T, et al. An indirect immuno-fluorescence method facilitates detection of thrombospondin type 1 domain-containing 7A-Specific antibodies in membranous nephropathy[J]. J Am Soc Nephrol, 2017, 28(2): 520-531., articleTitle=null, refAbstract=null), Reference(id=1330127196036902978, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127190273929227, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=Meyer-Schwesinger C, Lambeau G, Stahl RA. Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy[J]. N Engl J Med, 2015, 372(11): 1074-1075., articleTitle=null, refAbstract=null), Reference(id=1330127196099817539, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127190273929227, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=Debiec H, Guigonis V, Mougenot B, et al. Antenatal membranous glomerulonephritis due to anti-neutral endopeptidase antibodies[J]. N Engl J Med, 2002, 346(26): 2053-2060., articleTitle=null, refAbstract=null), Reference(id=1330127196158537796, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127190273929227, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=Bruschi M, Carnevali ML, Murtas C, et al. Direct characterization of target podocyte antigens and auto-antibodies in human membranous glomerulonephritis: Alfa-enolase and borderline antigens[J]. J Proteomics, 2011, 74(10): 2008-2017., articleTitle=null, refAbstract=null), Reference(id=1330127196229840965, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127190273929227, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[29], rfOrder=28, authorNames=null, journalName=null, refType=null, unstructuredReference=Murtas C, Bruschi M, Candiano G, et al. Coexistence of different circulating anti-podocyte antibodies in membranous nephropathy[J]. Clin J Am Soc Nephrol, 2012, 7(9): 1394-1400., articleTitle=null, refAbstract=null), Reference(id=1330127196347281478, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127190273929227, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[30], rfOrder=29, authorNames=null, journalName=null, refType=null, unstructuredReference=Kidney Disease (2012) Improving global outcomes (KDIGO) glomerulonephritis work group. KDIGO clinical practice guideline for glomerulonephritis[J]. Kidney Int Suppl, 2012, 2(2): 186-197., articleTitle=null, refAbstract=null), Reference(id=1330127196439556167, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127190273929227, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[31], rfOrder=30, authorNames=null, journalName=null, refType=null, unstructuredReference=Polanco N, Gutierrez E, Covarsi A, et al. Spontaneous remission of nephrotic syndrome in idiopathic membranous nephropathy[J]. J Am Soc Nephrol, 2010, 21(4): 697-704., articleTitle=null, refAbstract=null), Reference(id=1330127196577968200, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127190273929227, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[32], rfOrder=31, authorNames=null, journalName=null, refType=null, unstructuredReference=du Buf-Vereijken PW, Branten AJ, Wetzels JF. Idiopathic membranous nephropathy: outline and rationale of a treatment strategy[J]. Am J Kidney Dis, 2005, 46(6): 1012-1029., articleTitle=null, refAbstract=null), Reference(id=1330127196661854281, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127190273929227, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[33], rfOrder=32, authorNames=null, journalName=null, refType=null, unstructuredReference=Lionaki S, Derebail VK, Hogan SL, et al. Venous thromboembolism in patients with membranous nephropathy[J]. Clin J Am Soc Nephrol, 2012, 7(1): 43-51., articleTitle=null, refAbstract=null), Reference(id=1330127198280855628, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127190273929227, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[34], rfOrder=33, authorNames=null, journalName=null, refType=null, unstructuredReference=Caro J, Gutierrez-Solis E, Rojas-Rivera J, et al. Predictors of response and relapse in patients with idiopathic membranous nephropathy treated with tacrolimus[J]. Nephrol Dial Transplant, 2015, 30(3): 467-474., articleTitle=null, refAbstract=null), Reference(id=1330127198389907533, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127190273929227, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[35], rfOrder=34, authorNames=null, journalName=null, refType=null, unstructuredReference=Zhu LB, Liu LL, Yao L, et al. Efficacy and safety of tacrolimus versus cyclophosphamide for primary membranous nephropathy: a meta-analysis[J]. Drugs, 2017, 77(2): 187-199., articleTitle=null, refAbstract=null), Reference(id=1330127198469599310, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127190273929227, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[36], rfOrder=35, authorNames=null, journalName=null, refType=null, unstructuredReference=Alexopoulos E, Papagianni A, Tsamelashvili M, et al. Induction and long-term treatment with cyclosporine in membranous nephropathy with the nephrotic syndrome[J]. Nephrol Dial Transplant, 2006, 21(11): 3127-3132., articleTitle=null, refAbstract=null), Reference(id=1330127198536708175, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127190273929227, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[37], rfOrder=36, authorNames=null, journalName=null, refType=null, unstructuredReference=Miller G, Zimmerman RR, Radhakrishnan J, et al. Use of mycophenolate mofetil in resistant membranous nephropathy[J]. Am J Kidney Dis, 2000, 36(2): 250-256., articleTitle=null, refAbstract=null), Reference(id=1330127198612205648, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127190273929227, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[38], rfOrder=37, authorNames=null, journalName=null, refType=null, unstructuredReference=Dussol B, Morange S, Burtey S, et al. Mycophenolate mofetil monotherapy in membranous nephropathy: a 1-year randomized controlled trial[J]. Am J Kidney Dis, 2008, 52(4): 699-705., articleTitle=null, refAbstract=null), Reference(id=1330127198683508817, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127190273929227, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[39], rfOrder=38, authorNames=null, journalName=null, refType=null, unstructuredReference=Branten AJ, du Buf-Vereijken PW, Vervloet M, et al. Mycophenolate mofetil in idiopathic membranous nephropathy: a clinical trial with comparison to a historic control group treated with cyclophosphamide[J]. Am J Kidney Dis, 2007, 50(2): 248-256., articleTitle=null, refAbstract=null), Reference(id=1330127198759006290, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127190273929227, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[40], rfOrder=39, authorNames=null, journalName=null, refType=null, unstructuredReference=Remuzzi G, Chiurchiu C, Abbate M, et al. Rituximab for idiopathic membranous nephropathy[J]. Lancet, 2002, 360(9337): 923-924., articleTitle=null, refAbstract=null), Reference(id=1330127198834503763, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127190273929227, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[41], rfOrder=40, authorNames=null, journalName=null, refType=null, unstructuredReference=Fervenza FC, Cosio FG, Erickson SB, et al. Rituximab treatment of idiopathic membranous nephropathy[J]. Kidney Int, 2008, 73(1): 117-125., articleTitle=null, refAbstract=null), Reference(id=1330127198918389844, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127190273929227, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[42], rfOrder=41, authorNames=null, journalName=null, refType=null, unstructuredReference=Fervenza FC, Abraham RS, Erickson SB, et al. Rituximab therapy in idiopathic membranous nephropathy: a 2-year study[J]. Clin J Am Soc Nephrol, 2010, 5(12): 2188-2198., articleTitle=null, refAbstract=null), Reference(id=1330127199006470229, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127190273929227, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[43], rfOrder=42, authorNames=null, journalName=null, refType=null, unstructuredReference=Ruggenenti P, Cravedi P, Chianca A, et al. Rituximab in idiopathic membranous nephropathy[J]. J Am Soc Nephrol, 2012, 23(8): 1416-1425., articleTitle=null, refAbstract=null), Reference(id=1330127199111327830, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127190273929227, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[44], rfOrder=43, authorNames=null, journalName=null, refType=null, unstructuredReference=Dahan K, Debiec H, Plaisier E, et al. Rituximab for severe membranous nephropathy: a 6-month trial with extended follow-up[J]. J Am Soc Nephrol, 2017, 28(1): 348-358., articleTitle=null, refAbstract=null), Reference(id=1330127199174242391, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127190273929227, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[45], rfOrder=44, authorNames=null, journalName=null, refType=null, unstructuredReference=Ruggenenti P, Fervenza FC, Remuzzi G. Treatment of membranous nephropathy: time for a paradigm shift[J]. Nat Rev Nephrol, 2017, 13(9): 563-579., articleTitle=null, refAbstract=null), Reference(id=1330127199245545560, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127190273929227, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[46], rfOrder=45, authorNames=null, journalName=null, refType=null, unstructuredReference=Lindskog A, Ebefors K, Johansson ME, et al. Melanocortin 1 receptor agonists reduce proteinuria[J]. J Am Soc Nephrol, 2010, 21(8): 1290-1298., articleTitle=null, refAbstract=null), Reference(id=1330127199304265817, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127190273929227, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[47], rfOrder=46, authorNames=null, journalName=null, refType=null, unstructuredReference=Bomback AS, Tumlin JA, Baranski J, et al. Treatment of nephrotic syndrome with adrenocorticotropic hormone (ACTH) gel[J]. Drug Des Devel Ther, 2011, 5: 147-153., articleTitle=null, refAbstract=null), Reference(id=1330127199367180378, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127190273929227, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[48], rfOrder=47, authorNames=null, journalName=null, refType=null, unstructuredReference=Hladunewich MA, Cattran D, Beck LH, et al. A pilot study to determine the dose and effectiveness of adrenocorticotrophic hormone (H. P. Acthar(R) Gel) in nephrotic syndrome due to idiopathic membranous nephropathy[J]. Nephrol Dial Transplant, 2014, 29(8): 1570-1577., articleTitle=null, refAbstract=null), Reference(id=1330127199438483547, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127190273929227, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[49], rfOrder=48, authorNames=null, journalName=null, refType=null, unstructuredReference=van de Logt AE, Beerenhout CH, Brink HS, et al. Synthetic ACTH in high risk patients with idiopathic membranous nephropathy: a prospective, open label cohort study[J]. PLoS One, 2015, 10(11): e142033-e142033., articleTitle=null, refAbstract=null), Reference(id=1330127199497203804, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127190273929227, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[50], rfOrder=49, authorNames=null, journalName=null, refType=null, unstructuredReference=左科, 李世军, 吴燕, 等. 雷公藤多苷治疗特发性膜性肾病的前瞻性随机对照研究[J]. 肾脏病与透析肾移植杂志, 2014, 23(6): 507-511., articleTitle=null, refAbstract=null), Reference(id=1330127199560118365, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127190273929227, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[51], rfOrder=50, authorNames=null, journalName=null, refType=null, unstructuredReference=曲巍, 刘楠, 陈莹, 等. 雷公藤多苷联合血管紧张素Ⅱ受体拮抗剂治疗特发性膜性肾病的疗效观察[J]. 世界临床药物, 2016, 37(3): 194-198., articleTitle=null, refAbstract=null), Reference(id=1330127199623032926, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127190273929227, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[52], rfOrder=51, authorNames=null, journalName=null, refType=null, unstructuredReference=Hartono C, Chung M, Kuo SF, et al. Bortezomib therapy for nephrotic syndrome due to idiopathic membranous nephropathy[J]. J Nephrol, 2014, 27(1): 103-106., articleTitle=null, refAbstract=null), Reference(id=1330127199685947487, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127190273929227, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[53], rfOrder=52, authorNames=null, journalName=null, refType=null, unstructuredReference=Barbari A, Chehadi R, Kfoury AH, et al. Bortezomib as a novel approach to early recurrent membranous glomerulonephritis after kidney transplant refractory to combined conventional rituximab therapy[J]. Exp Clin Transplant, 2017, 15(3): 350-354., articleTitle=null, refAbstract=null)], funds=[Fund(id=1330127193927168037, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127190273929227, awardId=81670635, language=CN, fundingSource=国家自然科学基金面上项目(81670635), fundOrder=null, country=null), Fund(id=1330127193990082598, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127190273929227, awardId=2016J01532, language=CN, fundingSource=福建省自然科学基金项目(2016J01532), fundOrder=null, country=null), Fund(id=1330127194052997159, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127190273929227, awardId=2016-ZQN-36, language=CN, fundingSource=福建省卫生计生中青年骨干人才培养项目(2016-ZQN-36), fundOrder=null, country=null)], companyList=[AuthorCompany(id=1330127191167315984, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127190273929227, xref=null, ext=[AuthorCompanyExt(id=1330127191175704593, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127190273929227, companyId=1330127191167315984, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Nephrology, First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, China), AuthorCompanyExt(id=1330127191184093202, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127190273929227, companyId=1330127191167315984, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=福建医科大学附属第一医院肾内科,福州 350005)])], figs=null, attaches=null, journal=Journal(id=1319689997550452896, delFlag=0, nameCn=世界临床药物, nameEn=World Clinical Drug, nameHistory1=null, nameHistory2=null, issn=1672-9188, eissn=null, cn=31-1939/R, coden=SLYHAA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=9c6IkcJKa1cF20h1u6lJeQ==, journalPrice=null, startedYear=null, abbrevIsoEn=World Clinical Drug, journalRemark=null, publicationField=null, createdTime=1792568214072, updatedTime=1792747519563, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=S, firstLetterEn=S, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=9c6IkcJKa1cF20h1u6lJeQ==, picEn=MRqUlTwfL6oqIHNy7eyFZQ==, jcr=null, cjcr=null, exts=[JournalExt(id=1320442059660570919, language=CN, name=世界临床药物, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519650, updatedTime=1792747519650, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1320442059723485480, language=EN, name=World Clinical Drug, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519665, updatedTime=1792747519665, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1319690329412173987, websiteList=[Website(id=1321427104911179915, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/CN, language=CN, createTime=1792982372739, createBy=18614031015, updateTime=1792982514949, updateBy=18614031015, name=世界临床药物-中文, tplId=1146099689490845704, title=世界临床药物, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428428256031726, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=articleTextType, value=kx, createTime=1792982688249, updateTime=1792982688249, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428193117163, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982688234, updateTime=1792982688234, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428302169073, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=grayFlag, value=0, createTime=1792982688260, updateTime=1792982688260, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428172145642, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982688229, updateTime=1792982688229, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428327334899, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=minRunFlag, value=0, createTime=1792982688266, updateTime=1792982688266, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428226671597, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic, createTime=1792982688242, updateTime=1792982688242, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428314751986, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=silenceFlag, value=0, createTime=1792982688263, updateTime=1792982688263, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428209894380, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982688238, updateTime=1792982688238, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428268614639, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeColor, value=null, createTime=1792982688252, updateTime=1792982688252, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428289586160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982688257, updateTime=1792982688257, creator=18614031015, updator=18614031015)]), Website(id=1321427104990871693, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/EN, language=EN, createTime=1792982372758, createBy=18614031015, updateTime=1792982556355, updateBy=18614031015, name=世界临床药物-英文, tplId=1146101810881728533, title=World Clinical Drug, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428446820021244, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=articleTextType, value=kx, createTime=1792982692675, updateTime=1792982692675, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446757106681, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982692660, updateTime=1792982692660, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447109428223, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=grayFlag, value=0, createTime=1792982692744, updateTime=1792982692744, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446736135160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982692655, updateTime=1792982692655, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447142981632, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=minRunFlag, value=0, createTime=1792982692752, updateTime=1792982692752, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446790661115, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic, createTime=1792982692668, updateTime=1792982692668, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447130399745, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=silenceFlag, value=0, createTime=1792982692749, updateTime=1792982692749, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446769689594, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982692663, updateTime=1792982692663, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446832604157, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeColor, value=null, createTime=1792982692678, updateTime=1792982692678, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447092651006, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982692740, updateTime=1792982692740, creator=18614031015, updator=18614031015)])], journalTitle=世界临床药物, weixinUrl=null, journalUrl=http://www.jwph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=World Clinical Drug, journalPhotoCn=9c6IkcJKa1cF20h1u6lJeQ==, journalPhotoEn=MRqUlTwfL6oqIHNy7eyFZQ==, journalFirstLetter=S, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2018.02.001, detailUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2018.02.001, pdfUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/PDF/10.13683/j.wph.2018.02.001, pdfUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/PDF/10.13683/j.wph.2018.02.001, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1518192000000, fullTextJson=null, articleText=null, reference=null)
收藏切换
原发性膜性肾病的诊治进展
潘阳彬 , 万建新 *
世界临床药物 | 医药专论·慢性肾脏病的诊疗专题 2018,39(2): 73-79
收起
收藏切换
世界临床药物 |医药专论·慢性肾脏病的诊疗专题 2018 , 39 (2) : 73 -79
原发性膜性肾病的诊治进展
全屏
[Author(id=1330127191259590676, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127190273929227, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330127191339282454, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127190273929227, authorId=1330127191259590676, language=EN, stringName=Yang-bin PAN, firstName=Yang-bin, middleName=null, lastName=PAN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Nephrology, First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330127191406391319, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127190273929227, authorId=1330127191259590676, language=CN, stringName=潘阳彬, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=福建医科大学附属第一医院肾内科,福州 350005, bio={"content":"

潘阳彬,副主任医师,副教授,硕士生导师,研究方向:肾小球疾病的发病机制及治疗,血液净化治疗。

"}, bioImg=null, bioContent=

潘阳彬,副主任医师,副教授,硕士生导师,研究方向:肾小球疾病的发病机制及治疗,血液净化治疗。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330127191167315984, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127190273929227, xref=null, ext=[AuthorCompanyExt(id=1330127191175704593, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127190273929227, companyId=1330127191167315984, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Nephrology, First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, China), AuthorCompanyExt(id=1330127191184093202, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127190273929227, companyId=1330127191167315984, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=福建医科大学附属第一医院肾内科,福州 350005)])]), Author(id=1330127191469305881, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127190273929227, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1330127191561580571, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127190273929227, authorId=1330127191469305881, language=EN, stringName=Jian-xin WAN, firstName=Jian-xin, middleName=null, lastName=WAN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=Department of Nephrology, First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330127191641272348, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127190273929227, authorId=1330127191469305881, language=CN, stringName=万建新, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=福建医科大学附属第一医院肾内科,福州 350005, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330127191167315984, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127190273929227, xref=null, ext=[AuthorCompanyExt(id=1330127191175704593, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127190273929227, companyId=1330127191167315984, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Nephrology, First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, China), AuthorCompanyExt(id=1330127191184093202, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127190273929227, companyId=1330127191167315984, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=福建医科大学附属第一医院肾内科,福州 350005)])])]
潘阳彬, 万建新*
作者信息
  • 福建医科大学附属第一医院肾内科,福州 350005
通讯作者:
万建新,主任医师,教授,博士生导师,研究方向:损伤肾脏的修复与再生。
作者简介:

潘阳彬,副主任医师,副教授,硕士生导师,研究方向:肾小球疾病的发病机制及治疗,血液净化治疗。

Research progress on the diagnosis and treatment of primary membranous nephropathy
Yang-bin PAN, Jian-xin WAN*
Affiliations
  • Department of Nephrology, First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, China
出版时间: 2018-02-10 doi: 10.13683/j.wph.2018.02.001
文章导航
收藏切换

原发性膜性肾病(PMN)[又称特发性膜性肾病(IMN)]是膜性肾病的一种主要病理类型,随着抗磷脂酶A2受体抗体、抗Ⅰ型血小板反应蛋白7A域抗体等的相继开发,新型免疫抑制剂(如他克莫司)、单克隆抗体(如利妥昔单抗)等药物在IMN中的应用,IMN的诊断和治疗得到较大进展,本文综述IMN的诊断和治疗进展。

原发性膜性肾病(PMN)  /  特发性膜性肾病(IMN)  /  诊断  /  治疗

Primary membranous nephropathy (PMN) [or idiopathic membranous nephropathy (IMN)] belongs to one of the most common pathological type of membranous glomerular nephropathy. As the development of anti-phospholipase A2 receptor antibody and anti-thrombospondin type-1 domain-containing 7A antibody for IMN treatment, the new immune-suppressants such as tacrolimus, and monoclonal antibodies such as rituximab have been successively used in IMN treatment. This review describes the recent progress in IMN diagnosis and its treatment.

primary membranous nephropathy (PMN)  /  idiopathic membranous nephropathy (IMN)  /  diagnosis  /  treatment
潘阳彬, 万建新. 原发性膜性肾病的诊治进展. 世界临床药物, 2018 , 39 (2) : 73 -79 . DOI: 10.13683/j.wph.2018.02.001
Yang-bin PAN, Jian-xin WAN. Research progress on the diagnosis and treatment of primary membranous nephropathy[J]. World Clinical Drug, 2018 , 39 (2) : 73 -79 . DOI: 10.13683/j.wph.2018.02.001
  • 国家自然科学基金面上项目(81670635)
  • 福建省自然科学基金项目(2016J01532)
  • 福建省卫生计生中青年骨干人才培养项目(2016-ZQN-36)
参考文献 引证文献
排序方式:
[1]
Xu X, Wang G, Chen N, et al. Long-term exposure to air pollution and increased risk of membranous nephropathy in China[J]. J Am Soc Nephrol, 2016, 27(12): 3739-3746.
[2]
Zhu P, Zhou FD, Wang SX, et al. Increasing frequency of idiopathic membranous nephropathy in primary glomerular disease: a 10-year renal biopsy study from a single Chinese nephrology centre[J]. Nephrology (Carlton), 2015, 20(8): 560-566.
[3]
Glassock RJ. The pathogenesis of idiopathic membranous nephropathy: a 50-year odyssey[J]. Am J Kidney Dis, 2010, 56(1): 157-167.
[4]
Mundel P, Shankland SJ. Podocyte biology and response to injury[J]. J Am Soc Nephrol, 2002, 13(12): 3005-3015.
[5]
Huang CC, Lehman A, Albawardi A, et al. IgG subclass staining in renal biopsies with membranous glomerulonephritis indicates subclass switch during disease progression[J]. Mod Pathol, 2013, 26(6): 799-805.
[6]
Beck LJ, Bonegio RG, Lambeau G, et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy[J]. N Engl J Med, 2009, 361(1): 11-21.
[7]
Sueta S, Kondo M, Matsubara T, et al. Membranous nephropathy associated with type 1 autoimmune pancreatitis and dominant glomerular IgG4 deposit[J]. CEN Case Rep, 2014, 3(1): 18-23.
[8]
Filippone EJ. Idiopathic membranous nephropathy and IgG4: an interesting relationship[J]. Clin Nephrol, 2014, 82(1): 7-15.
[9]
Hu SL, Wang D, Gou WJ, et al. Diagnostic value of phospholipase A2 receptor in idiopathic membranous nephropathy: a systematic review and meta-analysis[J]. J Nephrol, 2014, 27(2): 111-116.
[10]
Hofstra JM, Wetzels JF. Phospholipase A2 receptor antibodies in membranous nephropathy: unresolved issues[J]. J Am Soc Nephrol, 2014, 25(6): 1137-1139.
[11]
De-Vriese AS, Glassock RJ, Nath KA, et al. A proposal for a serology-based approach to membranous nephropathy[J]. J Am Soc Nephrol, 2017, 28(2): 421-430.
[12]
Wang C, Lu H, Yang C, et al. Progress on the M-type phospholipase A2 receptor in idiopathic membranous nephropathy[J]. Chin Med J (Engl), 2014, 127(10): 1960-1963.
[13]
Koziol M, Sikora A, Koziol-Montewka M, et al. Preliminary results of research on a new marker of idiopathic membranous nephropathy: anti-PLA2R[J]. Pol Merkur Lekarski, 2014, 36(213): 171-174.
[14]
Dahnrich C, Komorowski L, Probst C, et al. Development of a standardized ELISA for the determination of autoantibodies against human M-type phospholipase A2 receptor in primary membranous nephropathy[J]. Clin Chim Acta, 2013, 421(1): 213-218.
[15]
Behnert A, Schiffer M, Muller-Deile J, et al. Antiphospholipase A(2) receptor autoantibodies: a comparison of three different immunoassays for the diagnosis of idiopathic membranous nephropathy[J]. J Immunol Res, 2014, 2014: 143274. doi: 10.1155/2014/143274.
[16]
Stanescu HC, Arcos-Burgos M, Medlar A, et al. Risk HLA-DQA1 and PLA(2)R1 alleles in idiopathic membranous nephropathy[J]. N Engl J Med, 2011, 364(7): 616-626.
[17]
Bullich G, Ballarin J, Oliver A, et al. HLA-DQA1 and PLA2R1 polymorphisms and risk of idiopathic membranous nephropathy[J]. Clin J Am Soc Nephrol, 2014, 9(2): 335-343.
[18]
Cui G, Zhang L, Xu Y, et al. Development of a high resolution melting method for genotyping of risk HLA-DQA1 and PLA2R1 alleles and ethnic distribution of these risk alleles[J]. Gene, 2013, 514(2): 125-130.
[19]
Lv J, Hou W, Zhou X, et al. Interaction between PLA2R1 and HLA-DQA1 variants associates with anti-PLA2R antibodies and membranous nephropathy[J]. J Am Soc Nephrol, 2013, 24(8): 1323-1329.
[20]
Tomas NM, Beck LJ, Meyer-Schwesinger C, et al. Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy[J]. N Engl J Med, 2014, 371(24): 2277-2287.
[21]
Iwakura T, Ohashi N, Kato A, et al. Prevalence of enhanced granular expression of thrombospondin type-1 domain-containing 7A in the glomeruli of Japanese patients with idiopathic membranous nephropathy[J]. PLoS One, 2015, 10(9): 138-141.
[22]
Larsen CP, Cossey LN, Beck LH. THSD7A staining of membranous glomerulopathy in clinical practice reveals cases with dual autoantibody positivity[J]. Mod Pathol, 2016, 29(4): 421-426.
[23]
Hoxha E, Harendza S, Pinnschmidt HO, et al. Spontaneous remission of proteinuria is a frequent event in phospholipase A2 receptor antibody-negative patients with membranous nephropathy[J]. Nephrol Dial Transplant, 2015, 30(11): 1862-1869.
[24]
Hoxha E, Wiech T, Stahl PR, et al. A Mechanism for cancer-associated membranous nephropathy[J]. N Engl J Med, 2016, 374(20): 1995-1996.
[25]
Hoxha E, Beck LJ, Wiech T, et al. An indirect immuno-fluorescence method facilitates detection of thrombospondin type 1 domain-containing 7A-Specific antibodies in membranous nephropathy[J]. J Am Soc Nephrol, 2017, 28(2): 520-531.
[26]
Meyer-Schwesinger C, Lambeau G, Stahl RA. Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy[J]. N Engl J Med, 2015, 372(11): 1074-1075.
[27]
Debiec H, Guigonis V, Mougenot B, et al. Antenatal membranous glomerulonephritis due to anti-neutral endopeptidase antibodies[J]. N Engl J Med, 2002, 346(26): 2053-2060.
[28]
Bruschi M, Carnevali ML, Murtas C, et al. Direct characterization of target podocyte antigens and auto-antibodies in human membranous glomerulonephritis: Alfa-enolase and borderline antigens[J]. J Proteomics, 2011, 74(10): 2008-2017.
[29]
Murtas C, Bruschi M, Candiano G, et al. Coexistence of different circulating anti-podocyte antibodies in membranous nephropathy[J]. Clin J Am Soc Nephrol, 2012, 7(9): 1394-1400.
[30]
Kidney Disease (2012) Improving global outcomes (KDIGO) glomerulonephritis work group. KDIGO clinical practice guideline for glomerulonephritis[J]. Kidney Int Suppl, 2012, 2(2): 186-197.
[31]
Polanco N, Gutierrez E, Covarsi A, et al. Spontaneous remission of nephrotic syndrome in idiopathic membranous nephropathy[J]. J Am Soc Nephrol, 2010, 21(4): 697-704.
[32]
du Buf-Vereijken PW, Branten AJ, Wetzels JF. Idiopathic membranous nephropathy: outline and rationale of a treatment strategy[J]. Am J Kidney Dis, 2005, 46(6): 1012-1029.
[33]
Lionaki S, Derebail VK, Hogan SL, et al. Venous thromboembolism in patients with membranous nephropathy[J]. Clin J Am Soc Nephrol, 2012, 7(1): 43-51.
[34]
Caro J, Gutierrez-Solis E, Rojas-Rivera J, et al. Predictors of response and relapse in patients with idiopathic membranous nephropathy treated with tacrolimus[J]. Nephrol Dial Transplant, 2015, 30(3): 467-474.
[35]
Zhu LB, Liu LL, Yao L, et al. Efficacy and safety of tacrolimus versus cyclophosphamide for primary membranous nephropathy: a meta-analysis[J]. Drugs, 2017, 77(2): 187-199.
[36]
Alexopoulos E, Papagianni A, Tsamelashvili M, et al. Induction and long-term treatment with cyclosporine in membranous nephropathy with the nephrotic syndrome[J]. Nephrol Dial Transplant, 2006, 21(11): 3127-3132.
[37]
Miller G, Zimmerman RR, Radhakrishnan J, et al. Use of mycophenolate mofetil in resistant membranous nephropathy[J]. Am J Kidney Dis, 2000, 36(2): 250-256.
[38]
Dussol B, Morange S, Burtey S, et al. Mycophenolate mofetil monotherapy in membranous nephropathy: a 1-year randomized controlled trial[J]. Am J Kidney Dis, 2008, 52(4): 699-705.
[39]
Branten AJ, du Buf-Vereijken PW, Vervloet M, et al. Mycophenolate mofetil in idiopathic membranous nephropathy: a clinical trial with comparison to a historic control group treated with cyclophosphamide[J]. Am J Kidney Dis, 2007, 50(2): 248-256.
[40]
Remuzzi G, Chiurchiu C, Abbate M, et al. Rituximab for idiopathic membranous nephropathy[J]. Lancet, 2002, 360(9337): 923-924.
[41]
Fervenza FC, Cosio FG, Erickson SB, et al. Rituximab treatment of idiopathic membranous nephropathy[J]. Kidney Int, 2008, 73(1): 117-125.
[42]
Fervenza FC, Abraham RS, Erickson SB, et al. Rituximab therapy in idiopathic membranous nephropathy: a 2-year study[J]. Clin J Am Soc Nephrol, 2010, 5(12): 2188-2198.
[43]
Ruggenenti P, Cravedi P, Chianca A, et al. Rituximab in idiopathic membranous nephropathy[J]. J Am Soc Nephrol, 2012, 23(8): 1416-1425.
[44]
Dahan K, Debiec H, Plaisier E, et al. Rituximab for severe membranous nephropathy: a 6-month trial with extended follow-up[J]. J Am Soc Nephrol, 2017, 28(1): 348-358.
[45]
Ruggenenti P, Fervenza FC, Remuzzi G. Treatment of membranous nephropathy: time for a paradigm shift[J]. Nat Rev Nephrol, 2017, 13(9): 563-579.
[46]
Lindskog A, Ebefors K, Johansson ME, et al. Melanocortin 1 receptor agonists reduce proteinuria[J]. J Am Soc Nephrol, 2010, 21(8): 1290-1298.
[47]
Bomback AS, Tumlin JA, Baranski J, et al. Treatment of nephrotic syndrome with adrenocorticotropic hormone (ACTH) gel[J]. Drug Des Devel Ther, 2011, 5: 147-153.
[48]
Hladunewich MA, Cattran D, Beck LH, et al. A pilot study to determine the dose and effectiveness of adrenocorticotrophic hormone (H. P. Acthar(R) Gel) in nephrotic syndrome due to idiopathic membranous nephropathy[J]. Nephrol Dial Transplant, 2014, 29(8): 1570-1577.
[49]
van de Logt AE, Beerenhout CH, Brink HS, et al. Synthetic ACTH in high risk patients with idiopathic membranous nephropathy: a prospective, open label cohort study[J]. PLoS One, 2015, 10(11): e142033-e142033.
[50]
左科, 李世军, 吴燕, 等. 雷公藤多苷治疗特发性膜性肾病的前瞻性随机对照研究[J]. 肾脏病与透析肾移植杂志, 2014, 23(6): 507-511.
[51]
曲巍, 刘楠, 陈莹, 等. 雷公藤多苷联合血管紧张素Ⅱ受体拮抗剂治疗特发性膜性肾病的疗效观察[J]. 世界临床药物, 2016, 37(3): 194-198.
[52]
Hartono C, Chung M, Kuo SF, et al. Bortezomib therapy for nephrotic syndrome due to idiopathic membranous nephropathy[J]. J Nephrol, 2014, 27(1): 103-106.
[53]
Barbari A, Chehadi R, Kfoury AH, et al. Bortezomib as a novel approach to early recurrent membranous glomerulonephritis after kidney transplant refractory to combined conventional rituximab therapy[J]. Exp Clin Transplant, 2017, 15(3): 350-354.
2018年第39卷第2期
7
1
0
引用本文
BibTeX
文章信息
doi: 10.13683/j.wph.2018.02.001
  • 接收时间:2017-10-11
  • 首发时间:2026-11-19
  • 出版时间:2018-02-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2017-10-11
  • 修回日期:2017-12-08
基金
国家自然科学基金面上项目(81670635)
福建省自然科学基金项目(2016J01532)
福建省卫生计生中青年骨干人才培养项目(2016-ZQN-36)
作者信息
    福建医科大学附属第一医院肾内科,福州 350005

通讯作者:

万建新,主任医师,教授,博士生导师,研究方向:损伤肾脏的修复与再生。
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2018.02.001
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏